Current levodopa challenge test (LCT) for deep brain stimulation (DBS) candidate screening in Parkinson’s disease (PD) relies on subjective clinical scales, limiting its predictive capacity for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results